Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Todd Neale

September 22, 2022

Presentation TCT 2022

Con

Presenter: Nihar Desai

September 19, 2022

Presentation TCT 2022

Pro

Presenter: Babar Basir

September 19, 2022

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From OCT Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

Presentation TCT 2022

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

Presenter: Toshiro Shinke

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

Presenter: Sanjit Jolly

September 19, 2022

Presentation TCT 2022

New and Emerging Pharmacology for ACS: Factor XI Inhibition

Presenter: C. Michael Gibson

September 19, 2022

Presentation TCT 2022

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

Presenter: William Fearon

September 19, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

Presentation TCT 2022

Short DAPT or De-Escalation After ACS

Presenter: Claudio Laudani

September 18, 2022

Presentation TCT 2022

Hemodynamic Support for High-Risk PCI in ACS

Presenter: Alaide Chieffo

September 17, 2022

Presentation TCT 2022

Management of No-Reflow in ACS

Presenter: Natalia Pinilla

September 17, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

Advertisement

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes

Con

Pro

Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

New and Emerging Pharmacology for ACS: Factor XI Inhibition

State-of-the Art: Top 10 Lessons We Have Learned In ACS Management

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Short DAPT or De-Escalation After ACS

Hemodynamic Support for High-Risk PCI in ACS

Management of No-Reflow in ACS

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content